Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial

Trial of Tocilizumab in Giant-Cell Arteritis

John H. Stone, Katie Tuckwell, Sophie Dimonaco et al. · New England Journal of Medicine · 2017 · 1.3K citations · Full text

2018 Update of the EULAR recommendations for the management of large vessel vasculitis

Bernhard Hellmich, Ana Águeda, Sara Monti et al. · Annals of the Rheumatic Diseases · 2019 · 1.1K citations · Full text

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

Dominique Baeten, Joachim Sieper, Jürgen Braun et al. · New England Journal of Medicine · 2015 · 973 citations · Full text

Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes

Anne Prøven, Sherine E. Gabriel, Carlos H. Orces et al. · Arthritis Care & Research · 2003 · 596 citations

Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

Peter M. Villiger, Sabine Adler, Stefan Kuchen et al. · The Lancet · 2016 · 572 citations

Autoimmune Disease, Vasculitis, Immunology +6